Clinical Trials Logo

Filter by:
NCT ID: NCT06090279 Not yet recruiting - Thoracic Trauma Clinical Trials

Feasibility of the Gamification of Incentive Spirometry in Trauma Patients

Start date: January 2025
Phase: N/A
Study type: Interventional

Gamification may be one solution that can increase the compliance in the use of devices like incentive spirometry.

NCT ID: NCT06090266 Recruiting - Cancer Clinical Trials

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Start date: October 24, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open-label, multicenter, first-in-human dose-escalation and expansion Phase 1-2 study designed to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of OR502 administered as a monotherapy and in combination with cemiplimab in subjects with advanced solid tumors.

NCT ID: NCT06090227 Recruiting - Clinical trials for Focal Segmental Glomerulosclerosis

AMPK-activation by Metformin in FSGS: AMP-FSGS

AMP-FSGS
Start date: December 14, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective of this study is to determine whether extended-release MF (in addition to standard of care (S-o-C)) is superior to placebo in reducing podocyte injury and promoting podocyte survival by 6-months in Focal Segmental Glomerulosclerosis (FSGS).

NCT ID: NCT06090097 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Knee Biofeedback Rehabilitation Through Game Therapy

KneeBRIGHT
Start date: January 2024
Phase: N/A
Study type: Interventional

The goal of this study is to learn about the effect of video-game based rehabilitation exercise for patients with knee osteoarthritis. The main question the study aims to answer is: do patients who exercise with the game have better functional outcomes and engagement compared to patients who do conventional exercise? Participants will complete 10 weeks of physical therapy exercise sessions that focus on quadriceps strengthening. Two sessions per week will be conducted in the clinic, and one session will be conducted at home each week. The interventional group will conduct all exercises using the KneeBRIGHT EMG sensors and game software. The control group will conduct all exercises following a standard physical therapy regimen. Researchers will compare knee function and engagement between the group who uses the game, and the group who does conventional exercise.

NCT ID: NCT06090071 Not yet recruiting - Photoaging Clinical Trials

Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.

Start date: December 2023
Phase: Phase 4
Study type: Interventional

This is a phase 4 trial evaluating the clinical effect of combining a placebo moisturizer and non-ablative laser to improve procedural outcomes in patients with facial dyschromia. This study's objective is to evaluate both the tolerability and improvement in signs of photoaging for a placebo moisturizer used in combination with a non-ablative laser. Physician assessments, patient reported outcomes, and digital photos will be captured.

NCT ID: NCT06089980 Recruiting - Clinical trials for Kratom Pharmacokinetics

Direct Observation Study of Kratom Product Effects Among Regular Consumers

Start date: April 1, 2024
Phase:
Study type: Observational

The goal of this observational clinical study is to is to learn more about how commercial kratom products affect healthy adults who consume them regularly. The main questions it aims to answer are: 1. What are the acute physiological, subjective, and cognitive effects of kratom following participant self-administration of a single oral dose of the participants usual kratom product at the participants typical dose? 2. What are the physiological, subjective, and cognitive effects associated with kratom product discontinuation among adults who use regularly? 3. What are the pharmacokinetics of kratom products consumed by adults who use regularly? On the first study day: Under direct observation, participants will self-administer a single oral dose of the participants own commercial kratom product that that is regularly taken and will consume it at the participants self-selected typical dose/serving. Following this, serial blood draws and urine collection will occur along with administration of validated questionnaires, tests, and continual monitoring. After this first study day, participants will no longer be permitted to use any of the participants kratom product during the study. On study nights/days 2-3: participants will reside a clinical research unit and be observed and evaluated for kratom withdrawal syndrome.

NCT ID: NCT06089967 Enrolling by invitation - Cancer Clinical Trials

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

IMBARC
Start date: October 5, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of this project is to collect body samples like blood and tissue and health information from people receiving immune-based treatment for cancer. The body samples and health information will be stored for future research to understand more about side effects related to immune-based treatments for cancer.

NCT ID: NCT06089954 Enrolling by invitation - Cancer Clinical Trials

Penn Medicine Biobank Return of Results Program

ROR
Start date: October 20, 2023
Phase: N/A
Study type: Interventional

The goal of this hybrid type 1 effectiveness-implementation study is to evaluate and compare different ways of delivering genetic research results to participants. The main questions the study aims to answer are: - Is sharing actionable genetic research results with participants through a multimedia patient-informed eHealth intervention (e.g. patient portal) no worse than sharing results by telephone or videoconference with a genetic counselor? - Will research participants access an eHealth educational intervention or chatbot education to learn about research results being offered and the option to decline learning their individual research results and how frequently participants choose to decline actionable research results? - Who benefits less and more from digital intervention with return of actionable research results and what barriers exist to using these tools for return of research results outside this study? Participants in the biobank will be offered digital tools to learn about research results being offered and the option to decline receiving these results. Those who don't decline and have an actionable result will be randomly assigned to receive their results with a genetic counselor or through an eHealth portal. Participants will complete surveys before and after receipt of results to understand patient experiences with these methods of education and return of results to determine if digital tools can be used to help ensure more patients get access to research results which could impact their health.

NCT ID: NCT06089824 Completed - Obesity Clinical Trials

Drug Utilisation of Mysimba/Contrave

DUS
Start date: September 2014
Phase:
Study type: Observational

This study will assess a retrospective cohort of users of Mysimba/Contrave with up to 548 days (~18 months) after initiation with treatment with Mysimba/Contrave. This study will describe Mysimba/Contrave utilisation and incidence of AESIs for users compliant and non-compliant with the SmPC.

NCT ID: NCT06089746 Not yet recruiting - Clinical trials for Lumbar Spinal Stenosis

Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans

LSS-NIPT
Start date: February 15, 2024
Phase: N/A
Study type: Interventional

Lumbosacral spinal stenosis (LSS) is a leading cause of limited mobility, reduced independence, and poor health outcomes in older adults, and is very common in older adult Veterans. Several years ago, major research studies indicated that surgery for LSS was more effective than usual (medical) management. Nonetheless, there are many patients for whom surgery is not the ideal therapy. There have been reports that modifications in daily activities including temporary use of a modified rolling walker and changes in sleep positioning may help relieve LSS. The investigators have assembled a VA team to study this carefully. The investigators will recruit a small group of older adult Veterans with LSS to try out this program; the investigators will monitor them closely for relief of their symptoms and improvements in walking. The investigators will, as part of this small study, try to understand potential barriers to use of this therapy. The investigators will interview the Veterans and healthcare providers to identify problems that may arise in trying this therapy. If this small study works, the investigators plan to expand the effort.